Response and outcomes of maintenance avelumab after platinum-based chemotherapy (PBC) in patients (pts) with advanced urothelial carcinoma (aUC): "Real world" experience.

被引：0

作者：

Bakaloudi, Dimitra Rafailia

Talukder, Rafee

Makrakis, Dimitrios

Agarwal, Neeraj

Tripathi, Nishita

Bamias, Aristotelis

Zakopoulou, Roubini

Brown, Jason

Korolewicz, James

Fulgenzi, Claudia A. M.

Jindal, Tanya

Murgic, Jure

Frobe, Ana

Johnson, Jeffrey

Drakaki, Alexandra

Rodriguez-Vida, Alejo

Rey-Cardenas, Macarena

Buznego, Lucia Andrea Alonso

Khaki, Ali Raza

Grivas, Petros

机构：

[1] Univ Washington, Seattle, WA USA

[2] Albert Einstein Coll Med, Dept Med, Jacobi Med Ctr, Bronx, NY USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[4] Univ Athens, Athina, Greece

[5] Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Dept Clin Therapeut, Sch Med, Athens, Greece

[6] Univ Hosp Seidman Canc Ctr, Div Oncol, Cleveland, OH USA

[7] Imperial Coll, London, England

[8] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England

[9] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[10] KBC Sestre Milosrdnice, Zagreb, ON, Croatia

[11] Mercy Univ, Zagreb Med Sch, Dept Oncol, Univ Hosp Ctr Sisters, Zagreb, Croatia

[12] Univ Iowa, Div Oncol, Dept Med, Iowa City, IA USA

[13] UCLA, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA USA

[14] Hosp Mar, IMIM Res Inst, Barcelona, Spain

[15] Hosp Univ 12 Octubre, Madrid, Spain

[16] Marque de Valdecilla Univ Hosp, Santander, Spain

[17] Stanford Univ, Stanford, CA USA

[18] Fred Hutchinson Canc Ctr, Seattle, WA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

472

引用

页数：1

共 50 条

[31] Real-world outcomes before and after the access to immunecheckpoint inhibitors (ICI) in advanced urothelial carcinoma (aUC)
Tapia, J. C.
Anguera Palacios, G.
Gavira, J.
Bosma, F.
Sanchez Del Rio, S.
Sanz Beltran, J.
Molina Perez, M. A.
Aguado Sorolla, M.
Piedra, A.
Maroto Rey, J. P.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1344 - S1344
[32] Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study
Narita, Takuma
Hatakeyama, Shingo
Numakura, Kazuyuki
Kobayashi, Mizuki
Muto, Yumina
Saito, Mitsuru
Narita, Shintaro
Tanaka, Toshikazu
Noro, Daisuke
Tokui, Noriko
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Habuchi, Tomonori
Ohyama, Chikara
INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 899 - 905
[33] Comprehensive metabolomic profiling of plasma from patients (pts) with metastatic urothelial carcinoma (mUC) receiving immune checkpoint inhibitors (ICI) or platinum-based chemotherapy (PBC).
El Zarif, Talal
Adib, Elio
Clish, Clary
Shukla, Sachet A.
Freeman, Dory
Thomas, Jonathan
Ravi, Praful
Tuff, Martha
McGregor, Bradley Alexander
Mantia, Charlene
Ravi, Arvind
Sonpavde, Guru P.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[34] Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.
Barthelemy, Philippe
Loriot, Yohann
Thibault, Constance
Gross-Goupil, Marine
Eymard, Jean Christophe
Voog, Eric
Abraham Jaillon, Christine
Le Moulec, Sylvestre
Chasseray, Matthieu
Gobert, Aurelien
Auberger, Benjamin
Viala, Caroline
Cabart, Mathilde
Kazan, Eyad
Lorgis, Veronique
Hilgers, Werner
Josse, Constant
Lambert, Prisca
Solbes, Marie-Noelle
Flechon, Aude
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 561 - 561
[35] Combination therapy with paclitaxel and gemcitabine after platinum-based chemotherapy in patients with advanced urothelial cancer
Harada, Mirii
Tomisaki, Ikko
Minato, Akinori
Onishi, Rei
Terado, Michikazu
Inatomi, Hisato
Fujimoto, Naohiro
INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 970 - 974
[36] Real-world treatment patterns and outcomes in US patients (pts) with advanced non-small cell lung cancer (NSCLC) after platinum-based chemotherapy (PBC) and anti-PD-(L)1 treatment
Velcheti, Vamsidhar
Moore, Julia
Wang, Huifen
Zhu, Xinmei
Samyshkin, Yevgeniy
Ward, Thomas
Christensen, Alena
Solem, Caitlyn
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[37] Explorer: a real-world study of maintenance rucaparib in women with recurrent high grade ovarian carcinoma after response to platinum-based chemotherapy
Glasspool, Rosalind
Mcconnachie, Alex
Haig, Caroline
Weeden, Sarah
Mcneish, Iain
Lord, Rosemary
Kristeleit, Rebecca
Purushothaman, Kiran
Dolan, Clare
Clamp, Andrew
Roxburgh, Patricia
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A219 - A220
[38] MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).
Gupta, Shilpa
Ballman, Karla V.
Galsky, Matt D.
Morris, Michael J.
Sridhar, Srikala S.
Chen, Ronald C.
Chan, Timothy An-Thy
Wen, Yujia
Grivas, Petros
Tan, Alan
Baghaie, Shiva
Rosenberg, Jonathan E.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[39] Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
Joaquim Bellmunt
Chensheng Willa Zhou
Stephanie A Mullane
Lillian Werner
Mary-Ellen Taplin
André P Fay
Toni K Choueiri
Anna Orsola
David Y Takeda
William C Hahn
Jaegil Kim
Guru Sonpavde
Michaela Bowden
British Journal of Cancer, 2016, 115 : 12 - 19
[40] Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
Bellmunt, Joaquim
Zhou, Chensheng Willa
Mullane, Stephanie A.
Werner, Lillian
Taplin, Mary-Ellen
Fay, Andre P.
Choueiri, Toni K.
Orsola, Anna
Takeda, David Y.
Hahn, William C.
Kim, Jaegil
Sonpavde, Guru
Bowden, Michaela
BRITISH JOURNAL OF CANCER, 2016, 115 (01) : 12 - 19

← 1 2 3 4 5 →